-
Add to Cart The item has been added15578-10A reversible, cell-permeable inhibitor of GSK3&alpha and GSK3&beta (IC<sub>50</sub> = 0.65 and 0. -
Add to Cart The item has been added15578-25A reversible, cell-permeable inhibitor of GSK3&alpha and GSK3&beta (IC<sub>50</sub> = 0.65 and 0. -
Add to Cart The item has been added15578-5A reversible, cell-permeable inhibitor of GSK3&alpha and GSK3&beta (IC<sub>50</sub> = 0.65 and 0. -
Add to Cart The item has been added13122-1An aminopyrimidine derivative that inhibits GSK3&alpha and GSK3&beta (IC50s = 10 and 6.7 nM, respectively) activates glycogen synthesis in CHO-IR cells (EC50 = 0. -
Add to Cart The item has been added13122-10An aminopyrimidine derivative that inhibits GSK3&alpha and GSK3&beta (IC50s = 10 and 6.7 nM, respectively) activates glycogen synthesis in CHO-IR cells (EC50 = 0. -
Add to Cart The item has been added13122-25An aminopyrimidine derivative that inhibits GSK3&alpha and GSK3&beta (IC50s = 10 and 6.7 nM, respectively) activates glycogen synthesis in CHO-IR cells (EC50 = 0. -
Add to Cart The item has been added13122-5An aminopyrimidine derivative that inhibits GSK3&alpha and GSK3&beta (IC50s = 10 and 6.7 nM, respectively) activates glycogen synthesis in CHO-IR cells (EC50 = 0. -
-
-
-
-
Add to Cart The item has been addedA9912-5 mgThomas Scientific
CHK1 inhibitor. It increases sensitivity to DNA-damaging compounds and inhibits proliferation of breast cancer and ovarian cancer cells. (C08-0488-989)
Price: $279.67List Price: $310.75AZD-7762 is an inhibitor of checkpoint kinase 1 (Chk1) that increases sensitivity to DNA-damaging compounds. AZD-7762 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for a variety of cancers.
